Results 181 to 190 of about 28,482,475 (369)

Factors Influencing the Production of H and M Antigens by Histoplasma capsulatum: Development and Evaluation of a Shake Culture Procedure1 [PDF]

, 1972
Hugh-Bert Ehrhard, Leo Pine
openalex   +1 more source

Complement Factor H Inhibits CD47‐Mediated Resolution of Inflammation

Immunity, 2017
B. Calippe, S. Augustin, Fanny Béguier, Hugo Charles-Messance, L. Poupel, Jean-Baptiste Conart, S. Hu, S. Lavalette, Alexandre Fauvet, J. Rayes, Olivier Levy, W. Raoul, C. Fitting, Thomas Denèfle, M. Pickering, C. Harris, S. Jorieux, P. Sullivan, J. Sahel, P. Karoyan, P. Sapieha, X. Guillonneau, E. Gautier, F. Sennlaub   +23 more
semanticscholar   +1 more source

TRPM4 contributes to cell death in prostate cancer tumor spheroids, and to extravasation and metastasis in a zebrafish xenograft model system

Molecular Oncology, EarlyView.
Transient receptor potential melastatin‐4 (TRPM4) is overexpressed in prostate cancer (PCa). Knockout of TRPM4 resulted in reduced PCa tumor spheroid size and decreased PCa tumor spheroid outgrowth. In addition, lack of TRPM4 increased cell death in PCa tumor spheroids.
Florian Bochen, Saurav Subedi, Federico La Manna, Sofia Jarrin, Irida Papapostolou, Marianna Kruithof‐de Julio, Christine Peinelt   +6 more
wiley   +1 more source

Isolation of Group H Streptococcal Competence Factor [PDF]

, 1973
Dennis Perry
openalex   +1 more source

Cystatin A promotes the antitumor activity of T helper type 1 cells and dendritic cells in murine models of pancreatic cancer

Molecular Oncology, EarlyView.
Pancreatic ductal adenocarcinoma (PDAC) is a disease with very poor prognosis due to therapeutic limitations. We investigated the antitumor effects of cystatin A (CSTA) in PDAC murine models. We are first to confirm that CSTA enhances T helper type 1‐mediated antitumor effects through promotion of dendritic cells and M1 macrophage activity. CSTA can be
Alessandro Nasti, Shingo Inagaki, Tuyen Thuy Bich Ho, Akihiro Seki, Keiko Yoshida, Kosuke Satomura, Yoshio Sakai, Shuichi Kaneko, Taro Yamashita   +8 more
wiley   +1 more source

Complement factor H in AMD: Bridging genetic associations and pathobiology

Progress in retinal and eye research, 2017
C. Toomey, L. V. Johnson, C. B. Rickman
semanticscholar   +1 more source

Integration of single‐cell and bulk RNA‐sequencing data reveals the prognostic potential of epithelial gene markers for prostate cancer

Molecular Oncology, EarlyView.
Prostate cancer is a leading malignancy with significant clinical heterogeneity in men. An 11‐gene signature derived from dysregulated epithelial cell markers effectively predicted biochemical recurrence‐free survival in patients who underwent radical surgery or radiotherapy.
Zhuofan Mou, Lorna W. Harries
wiley   +1 more source

Paroxysmal nocturnal hemoglobinuria: deficiency in factor H-like functions of the abnormal erythrocytes. [PDF]

, 1983
Michael K. Pangburn, Robert D. Schreiber, John S. Trombold, Hans J. Müller‐Eberhard   +3 more
openalex   +1 more source

Structural basis for sialic acid-mediated self-recognition by complement factor H.

Nature Chemical Biology, 2015
B. Blaum, J. Hannan, A. Herbert, D. Kavanagh, D. Uhrín, T. Stehle   +5 more
semanticscholar   +1 more source

Clinical significance of stratifying prostate cancer patients through specific circulating genes

Molecular Oncology, EarlyView.
We tested a specific panel of genes representative of luminal, neuroendocrine and stem‐like cells in the blood of prostate cancer patients, showing predictive value from diagnosis to late stages of disease. This approach allows monitoring of treatment responses and outcomes at specific time points in trajectories.
Seta Derderian, Edouard Jarry, Arynne Santos, Quentin Vesval, Lucie Hamel, Rafael Sanchez‐Salas, Alexis Rompré‐Brodeur, Wassim Kassouf, Raghu Rajan, Fadi Brimo, Marie Duclos, Armen Aprikian, Simone Chevalier   +12 more
wiley   +1 more source